Optimal Antiplatelet Therapy After PCI in High-Bleeding-Risk Patients

Abstract

Several recent randomized trials suggest that abbreviated dual antiplatelet therapy (DAPT; aspirin plus a platelet P2Y12 receptor antagonist) can